New monoclonal antibody promising against malaria sans any safety concerns: NEJM Medha Baranwal5 Aug 2022 9:15 AM ISTUSA: L9LS, a next-generation antimalarial monoclonal antibody, when administered intravenously or subcutaneously protected recipients against malaria...
Novartis Phase III CT protocol for Lanalumab Rejected by CDSCO Panel Dr. Divya Colin29 July 2022 6:00 PM ISTNew Delhi: Citing that the clinical trial protocol missed some inclusion/exclusion criteria, the Subject Expert Committee (SEC) functional under...
Omalizumab may reduce severe Asthma Exacerbations, finds study Dr.Niharika Harsha B29 July 2022 10:00 AM ISTNew Investigation into Asthma condition found that despite the atopic status, Omalizumab was effective in severe asthma. This was published in...
Subcutaneous Monoclonal Antibodies as good as IV infusion for reducing hospitalization in Covid-19: JAMA Medical Dialogues Editorial Team15 April 2022 9:45 AM ISTSubcutaneously given casirivimab and imdevimab to high-risk outpatients with mild to severe COVID-19 symptoms was linked with lower hospitalization...
Breakthrough COVID-19 Infections: Decoding scope of Monoclonal Antibody Dr. Kamal Kant Kohli7 Jan 2022 10:46 AM ISTDespite the effectiveness of COVID-19 vaccines, breakthrough infections have been reported. Breakthrough COVID-19 may occur in fully vaccinated...
Single-dose of monoclonal antibody may prevent malaria up to nine months: NIH trial Hina Zahid12 Aug 2021 9:02 PM ISTMonoclonal antibodies may represent a new approach for preventing malaria in travelers, military personnel and health care workers traveling to...
Abelacimab effectively prevents postoperative venous thromboembolism: NEJM Dr. Shravani Dali2 Aug 2021 9:00 AM ISTAbelacimab is effective when administrated in patients after total knee arthroplasty for the prevention of venous thromboembolism, suggests a study...
Dupilumab helps reduce exacerbations in kids with moderate-to-severe asthma: VOYAGE trial Hina Zahid29 May 2021 9:00 AM ISTNew York, NY: Dupilumab (Dupixent) significantly reduced exacerbations in patients aged 6 to <12 years with uncontrolled, moderate-to-severe...
Kerala procures 50 doses of monoclonal antibody to combat Nipah Medical Dialogues Bureau26 May 2018 1:46 PM ISTKozhikode: With the help of Indian Council of Medical Research and World Health Organisation, the Kerala government has procured about 50 doses of a...
